SI
Savara Inc
🇩🇪XFRA.YB4PGermanyHealthcare
€4.49EURdown -0.12 (-2.6%)OpenEnd of day6:56 PM
Price€4.49-0.12 (-2.6%)
Profile
- Healthcare
- Biotechnology
- Germany
Identity
- Exchange
- Frankfurt Stock Exchange . XFRA
- Type
- Stock
- ISIN
- US8051111016
- CUSIP
- Not reported
Company
- Employees
- 70
- Headquarters
- Yardley, United States
- Website
- https://www.savarapharma.com
- CEO
- Mr. Matthew Pauls J.D., M.B.A.
Market
- Shares outstanding
- 203.5M
- Market cap
- €913.57M
Key dates
- Next earnings
- Nov 11, 2026
Highlights
- Market cap
- €913.57M
- EPS LTM
- -$0.68calculatedCalculated by Finzer, not reported by the data provider.
- P/E LTM
- Not reported
- Div yield
- Not reported
Fundamentals (LTM)
- Revenue
- $0-100%down year on year
- Net income
- -$139.31M-26.26%down year on year
- Gross margin
- Not reported
- Free cash flow
- -$110.66M-11.32%down year on year
Other listings
These are the venues Finzer covers, not every venue that exists.
Business summary
No company summary reported yet.